Tower Research Capital (TRC)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-17,025
| Closed | -$36K | – | 4820 |
|
|
2018
Q3 | $36K | Buy |
17,025
+11,734
| +222% | +$24.8K | ﹤0.01% | 1975 |
|
|
2018
Q2 | $12K | Buy |
5,291
+5,212
| +6,597% | +$11.8K | ﹤0.01% | 2720 |
|
|
2018
Q1 | $0 | Buy |
+79
| New | – | ﹤0.01% | 4417 |
|
|
2017
Q4 | – | Sell |
-5,250
| Closed | -$24K | – | 4640 |
|
|
2017
Q3 | $24K | Sell |
5,250
-6,240
| -54% | -$28.5K | ﹤0.01% | 2635 |
|
|
2017
Q2 | $38K | Buy |
11,490
+8,099
| +239% | +$26.8K | ﹤0.01% | 896 |
|
|
2017
Q1 | $31K | Buy |
3,391
+3,286
| +3,130% | +$30K | ﹤0.01% | 1018 |
|
|
2016
Q4 | $1K | Sell |
105
-2,007
| -95% | -$19.1K | ﹤0.01% | 3757 |
|
|
2016
Q3 | $24K | Buy |
2,112
+1,075
| +104% | +$12.2K | ﹤0.01% | 1521 |
|
|
2016
Q2 | $13K | Sell |
1,037
-243
| -19% | -$3.05K | ﹤0.01% | 2633 |
|
|
2016
Q1 | $13K | Buy |
1,280
+973
| +317% | +$9.88K | ﹤0.01% | 1739 |
|
|
2015
Q4 | $7K | Buy |
+307
| New | +$7K | ﹤0.01% | 2707 |
|
|
2015
Q3 | – | Sell |
-1,382
| Closed | -$31K | – | 5739 |
|
|
2015
Q2 | $31K | Buy |
1,382
+490
| +55% | +$11K | ﹤0.01% | 1755 |
|
|
2015
Q1 | $23K | Buy |
892
+872
| +4,360% | +$22.5K | ﹤0.01% | 2161 |
|
|
2014
Q4 | $0 | Buy |
+20
| New | – | ﹤0.01% | 5566 |
|
|
2014
Q1 | – | Sell |
-4,102
| Closed | -$121K | – | 5631 |
|
|
2013
Q4 | $121K | Buy |
4,102
+3,902
| +1,951% | +$115K | 0.02% | 755 |
|
|
2013
Q3 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 4062 |
|